These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2351631)

  • 1. Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae.
    Nagy E; Hajdu E; Földes J
    J Antimicrob Chemother; 1990 Apr; 25(4):701-3. PubMed ID: 2351631
    [No Abstract]   [Full Text] [Related]  

  • 2. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M; Barry A; Fuchs P; Gerlach E; Hardy D; McLaughlin J
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
    Greenberg RN; Baker M; Meade DW; Chang Y; Danko LS
    J Antimicrob Chemother; 1993 Dec; 32(6):912-3. PubMed ID: 8144438
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
    Afridi FI; Farooqi BJ
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):358-62. PubMed ID: 22630093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P; Vera A; Martin-Luengo F
    Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014).
    Pfaller MA; Flamm RK; Duncan LR; Mendes RE; Jones RN; Sader HS
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):177-183. PubMed ID: 28341098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates.
    Eliopoulos GM; Klimm K; Ferraro MJ; Moellering RC
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):624-6. PubMed ID: 2506024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
    Moosdeen F; Williams J; Yamabe S
    Chemioterapia; 1987 Jun; 6(2 Suppl):206-7. PubMed ID: 2855613
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
    Fuchs PC; Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.
    Williams JD
    Clin Infect Dis; 1997 Mar; 24(3):494-7. PubMed ID: 9114205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
    Hill GB; Ayers OM; Everett BQ
    J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H
    Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
    Crosby MA; Gump DW
    Antimicrob Agents Chemother; 1982 Sep; 22(3):398-405. PubMed ID: 6291451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
    Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
    J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.
    Fuchs PC; Barry AL; Pfaller MA; Hardy DJ; McLaughlin JC; Gerlach EH
    Diagn Microbiol Infect Dis; 1993; 17(2):171-5. PubMed ID: 8243040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.
    Fass RJ; Gregory WW; D'Amato RF; Matsen JM; Wright DN; Young LS
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2256-9. PubMed ID: 2073118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of cefoperazone-sulbactam].
    Zhang Y; Zhang J; Zhou L
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Pei G; Mao Y; Sun Y
    Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.